ArticleBreast cancer research : BCR2015

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.

Betsy T Kren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.